health law policy

  • Read more: Changing How We Think (and Talk) About Public Health Law

    Changing How We Think (and Talk) About Public Health Law

    By Scott Burris, JD Marice Ashe, Donna Levin, Matthew Penn, Michelle Larkin and I have a new piece in the Annual Review of Public Health (also available on SSRN). We set out a “transdisciplinary model of public health law” that encompasses within the core of the field both the traditional public health law practice of…

  • Read more: A Conversation about… Tax Rates?: The Pfizer and Allergan Deal

    A Conversation about… Tax Rates?: The Pfizer and Allergan Deal

    By Dalia Deak Last week, Pfizer and Allergan announced a $155B merger that has the health care and policy world talking. The contours of the deal—in particular, where the new company will be based and the implications it has for the company’s tax rate— have raised important questions. Pfizer is a company with a long…

  • Read more: CMS Issues Notice Regarding Barriers to HCV Treatment

    CMS Issues Notice Regarding Barriers to HCV Treatment

    By Dalia Deak Yesterday, the Centers for Medicare & Medicaid Services (CMS) issued a notice that affirmed CMS’s commitment to provide prescription drugs to beneficiaries, specifically highlighting beneficiaries suffering from hepatitis C virus (HCV). The notice comes at a moment of heightened interest in the cost of prescription drugs (particularly on the federal level as…

  • Read more: UDI Adoption: A Necessary Step Towards Better Care for Patients with Implanted Devices

    UDI Adoption: A Necessary Step Towards Better Care for Patients with Implanted Devices

    By Dalia Deak In the United States, though many millions of individuals live with implanted devices, it may shock you to know that it is easier to recall tainted dog food than it is to recall a faulty pacemaker. This is due in large part to the lag of the medical device world behind most other…

  • Read more: A Cost Conundrum for Treating Small Patient Populations

    A Cost Conundrum for Treating Small Patient Populations

    By Dalia Deak The issue of drug pricing has been thrust center stage (again) after Turing Pharmaceuticals raised the price of daraprim from $13.50 to $750 per dose. The public issued a loud outcry, the pharmaceutical industry condemned the move, and presidential candidates are now discussing drug prices (as discussed previously on this blog). The reactions…

  • Read more: Check out the latest news from the Petrie-Flom Center!

    Check out the latest news from the Petrie-Flom Center!

    Check out the May 28th edition of the Petrie-Flom Center’s biweekly e-newsletter for the latest on events, affiliate news and scholarship, and job and fellowship opportunities in health law policy and bioethics. Featured in this edition: NEW EVENT! Petrie-Flom / Center for Bioethics Reception at ASLME 38th Annual Health Law Professors Conference June 4, 2015 7:30 – 9:30…

  • Read more: Check out the latest news from the Petrie-Flom Center!

    Check out the latest news from the Petrie-Flom Center!

    Check out the May 15th edition of the Petrie-Flom Center’s biweekly e-newsletter for the latest on events, affiliate news and scholarship, and job and fellowship opportunities in health law policy and bioethics. Featured in this edition: REGISTER NOW! Visible Solutions: How Neuroimaging Helps Law Re-envision Pain June 30, 2015, 8:00 AM – 5:00 PM Wasserstein Hall, Milstein West A Harvard…

  • Read more: TWO EVENTS THIS WEEK (5/7-5/9): “After Hobby Lobby: What Is Caesar’s, What Is God’s?” & “Law, Religion, and Health in America”

    TWO EVENTS THIS WEEK (5/7-5/9): “After Hobby Lobby: What Is Caesar’s, What Is God’s?” & “Law, Religion, and Health in America”

    Pre-Conference Session “After Hobby Lobby: What Is Caesar’s, What Is God’s?” May 7, 2015, 4:00 – 6:00 PM Wasserstein Hall, Milstein East BC Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] As prelude to the 2015 Petrie-Flom Center Annual Conference, “Law, Religion, and Health in America,” please join us for a pre-conference session examining the role of…

  • Read more: Cassandra C. Goes Home – Connecticut Misses an Opportunity

    Cassandra C. Goes Home – Connecticut Misses an Opportunity

    By Jonathan F. Will On Monday Cassandra C. was sent home from the hospital.  Her cancer is in remission after responding well to treatments.  Many will recall that those treatments were forced on Cassandra against her wishes and those of her mother.   Back in January, the Connecticut Supreme Court issued a two-page order agreeing with state…

  • Read more: TWO Upcoming Events (5/7-5/9): “After Hobby Lobby: What Is Caesar’s, What Is God’s?” & “Law, Religion, and Health in America”

    TWO Upcoming Events (5/7-5/9): “After Hobby Lobby: What Is Caesar’s, What Is God’s?” & “Law, Religion, and Health in America”

    Pre-Conference Session “After Hobby Lobby: What Is Caesar’s, What Is God’s?” May 7, 2015, 4:00 – 6:00 PM Wasserstein Hall, Milstein East BC Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA [Map] As prelude to the 2015 Petrie-Flom Center Annual Conference, “Law, Religion, and Health in America,” please join us for a pre-conference session examining the role of…